AVBP vs MSFT: Which Stock is Better?
Side-by-side comparison of ArriVent BioPharma, Inc. Common Stock and Microsoft Corporation in 2026
AVBP
ArriVent BioPharma, Inc. Common Stock
$30.15
MSFT
Microsoft Corporation
$496.32
Key Metrics Comparison
| Metric | AVBP | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.39B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | AVBP |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze AVBP
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AVBP or MSFT a better investment?
Comparing AVBP and MSFT: ArriVent BioPharma, Inc. Common Stock has a market cap of $1.39B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AVBP and MSFT?
AVBP (ArriVent BioPharma, Inc. Common Stock) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AVBP or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AVBP or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for AVBP.
Which company is more profitable: AVBP or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for AVBP.
Which is the larger company: AVBP or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.39B for AVBP.
Should I buy AVBP or MSFT in 2026?
Both AVBP and MSFT have investment merit. AVBP trades at $30.15 while MSFT trades at $496.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AVBP and MSFT stock?
Key differences: Market Cap ($1.39B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy AVBP or MSFT in 2026?
The choice between AVBP and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between AVBP and MSFT?
AVBP (ArriVent BioPharma, Inc. Common Stock) has a market cap of $1.39B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.